Adaptive Biotechnologies Spinout Digital Biotechnologies Raising $15M to Develop Clinical Sequencing Tech

Digital Biotechnologies, a newly formed Seattle-based subsidiary of Adaptive Biotechnologies, has raised fresh capital in the initial close of a Series A round that could total up to $15M.The company is developing DNA sequencing technology adjacent to Adaptive’s core focus on immune medicine and minimal residual disease (MRD) testing.